VX-809 (lumacaftor)

lumacaftor · Vertex Pharmaceuticals Incorporated

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VX-809 (lumacaftor), covering 2015-08-28 to 2015-08-28. Get the full timeline:

Most recent: Clinical Trial Update: Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation [Phase 2]